57 minutes ago • globenewswire.com
Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026
57 minutes ago • globenewswire.com
Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 20261 hour ago • investingnews.com
Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December 8, 2025Just now • tathya.in
IREDA CMD Backs Odisha’s Green Hydrogen, Circularity PushJust now • businesskorea.co.kr
SK Hynix Sweeps 2 Awards at Semiconductor Industry’s Highest Honor, GSA Awards5 minutes ago • pulse2.com
Cyberbay: Interview With Founder & CEO Felix Kan About The Cybersecurity Services Company7 minutes ago • marketsmojo.com
Parnax Lab Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals26 minutes ago • prnewswire.co.uk
Exosomes Market Led by North America with 53% Revenue Share and Global Market Size Set to Surpass USD 2B by 2030, Says Mordor Intelligence26 minutes ago • prnewswire.co.uk
Ancolia Holding AG Starts the Year Strong With CHF 480 Million Raised and Plans to Commit $300 Million to Emerging Technologies32 minutes ago • mychesco.com
USDA Unveils Sweeping Crop Insurance Overhaul as Nearly $1 Billion Flows Into Rural Georgia1 hour ago • weareiowa.com
Construction begins on ARL Rescue Intake & Rehabilitation Center1 hour ago • prnewswire.co.uk
SJTU International Gen Z Students Explore Shanghai's Innovation Ecosystem2 hours ago • businesswireindia.com
Turnbull & Asser Appoints Roberto Menichetti as Creative Director2 hours ago • businesswireindia.com
KRAFTON India Drops Another Wave of Official BGMI Redeem Codes for December 8th - New Rewards Up for Grabs2 hours ago • businesswireindia.com
FPT Strengthens South Korea Footprint with Strategic Partnership and Investment in Blueward7 minutes ago • biospace.com
Actio Biosciences Announces Preclinical Data Highlighting Ability of ABS-1230 to Potently and Selectively Inhibit KCNT1 and Significantly Reduce Seizure Activity7 minutes ago • smallcaps.com.au
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease7 minutes ago • defenseworld.net
Beacon Pointe Advisors LLC Cuts Stock Position in Viking Therapeutics, Inc. $VKTX2025-12-06 • jamestown.org
Russia Approves Expanding Rare Earths Mining And Refining Program2025-12-06 • bairdmaritime.com
Russia plans 27 per cent oil export rise in December to clear backlog2025-12-06 • ftnnews.com
River Rock announces first Russian hotel: River Rock Gelendzhik Bay opening in 20262 minutes ago • indianchemicalnews.com
AgroChem Summit 2025: Biologicals on the rise; policy, science support demandedJust now • tathya.in
IREDA CMD Backs Odisha’s Green Hydrogen, Circularity Push1 minute ago • marketsmojo.com
Bharat Electronics Sees High Value Trading Amid Sector Pressure45 minutes ago • bbc.com
Healthcare services at prison improving, CQC says1 hour ago • hulldailymail.co.uk
Hull construction firm collapsed owing £4m to scores of creditors, report shows49 minutes ago • felixonline.co.uk
KCL to begin puberty blockers trial in JanuaryStay ahead with real-time headlines from top sources, categorized by sector and country.